XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets (Tables)
12 Months Ended
Jul. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

Intangible assets consist of the following at:

 

        July 31,   July 31,
    Estimated Useful Lives   2020   2019
In-Process Research & Development       $ 6,302,427     $ 8,761,427  
Non-compete agreements   3 years     1,210,000       1,210,000  
Developed software/technology   5 years     131,000       131,000  
Intellectual Property    5 years     2,459,000       —    
Patents   20 years     51,274       51,274  
          10,153,701       10,153,701  
Less accumulated amortization         (788,175 )     (319,432 )
        $ 9,365,526     $ 9,834,269  
Estimated amortization expense

The estimated amortization expense remainder of the current fiscal year and for the next five years and thereafter is as follows:

 

Year Ending July 31,   Amount
2021   $ 923,897  
2022     654,189  
2023     520,564  
2024     500,914  
2025     458,202  
Thereafter     5,334  
 Total   $ 3,063,099  
Changes in value of goodwill

Changes in the value of goodwill:

Balance as of July 31, 2018   $ —   
Acquisition of Veneto (revaluation)     15,051,768  
Acquisition of Regentys (revaluation)     13,834,581  
Acquisition of Olaregen (revaluation)     9,411,224  
Balance as of July 31, 2019   $ 38,297,573  
Acquisition of MediSource and Pantheon     603,553  
Impairment of Veneto     (3,808,231 )
Impairment of MediSource and Pantheon     (603,553 )
Balance as of July 31, 2020   $ 34,489,342